Risk factors associated with immunoprophylaxis failure against mother to child transmission of hepatitis B virus and hepatitis B vaccination status in Yunnan province,China |
| |
Affiliation: | 1. Department of Pharmacology, School of Pharmacy, Fudan University, Shanghai 201203, China;2. School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China;3. Department of Cardiology, Children''s Hospital of Fudan University, Shanghai 201102, China;4. Institute of Biomedical Sciences, Fudan University, Shanghai 200032, China;5. Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, 117597, Singapore |
| |
Abstract: | ObjectiveTo explore the risk factors associated with immunoprophylaxis failure against mother to child transmission of hepatitis B virus (HBV) and hepatitis B vaccination status in Yunnan province, China.MethodsMulticenter cluster sampling was used to select pregnant women who were positive for hepatitis B surface antigen (HBsAg). HBV immunoprophylaxis was carried out for the newborns. Blood samples were collected and tested for HBV markers from 7 to 10 month old infants. The factors were analyzed by univariate and logistic regression.ResultsA total of 2765 mothers and their infants were enrolled. The failure rate of prevention of mother to child transmission (PMTCT) was 4.12%. The rate of timely HepB1 vaccination within 24 h was 98.04%, the rate of three-dose vaccination was 92.30% and the rate of hepatitis B immune globulin (HBIG) administration was 68.97%. Place of residence, maternal education, gestational age and birth weight were related to administration of HBV immunoprophylaxis. It was remarkable that the rate of HBIG administration of infants was only 63.89% with whose mothers were both HBsAg and hepatitis B e antigen (HBeAg)-positive. Further analysis showed that there were three risk factors associated with HBV immunoprophylaxis failure: mothers who were positive for HBsAg and HBeAg, maternal HBVDNA level, and HBIG administration or not.ConclusionsPMTCT of HBV was well implemented in Yunnan. However, in order to achieve optimal prevention of vertical HBV transmission, it is mandatory to make additional efforts to improve the implementation of regulatory HBV immunoprophylaxis, especially for HBsAg-positive pregnant women. |
| |
Keywords: | Hepatitis B virus Immunoprophylaxis Mother-to-child transmission Risk factor |
本文献已被 ScienceDirect 等数据库收录! |
|